TABLE 3.
Sample | Age (yr) | Alpha diversitya
|
|||||
---|---|---|---|---|---|---|---|
Shannon index |
PD |
||||||
Avg | SE | P value | Avg | SE | P value | ||
Untreated | 19,000 | 7.53 | 0.10 | 1.3 × 10−5b | 37.82 | 0.69 | 1.7 × 10−6b |
27,000 | 4.84 | 0.11 | 0.1150c | 16.25 | 0.43 | 1.7 × 10−2c | |
33,000 | 5.33 | 0.12 | 3.8 × 10−3d | 21.63 | 0.58 | 1.3 × 10−2d | |
DNA depleted | 19,000 | 7.70 | 0.09 | 3.4 × 10−3b | 38.51 | 0.71 | 1.2 × 10−3b |
27,000 | 4.98 | 0.08 | 0.2293c | 16.50 | 0.34 | 0.0771c | |
33,000 | 5.28 | 0.13 | 0.0605d | 21.92 | 0.46 | 0.0771d | |
Endospore enriched | 19,000 | 7.50 | 0.08 | 1.6 × 10−3b | 32.83 | 0.53 | 1.6 × 10−3b |
27,000 | 4.00 | 0.18 | 0.1039c | 12.55 | 0.79 | 0.1039c | |
33,000 | 5.34 | 0.30 | 0.0990d | 18.15 | 0.94 | 0.0990d |
Alpha diversity estimates based on 16S rRNA gene sequences for the untreated samples, PMA-treated samples, and endospore-enriched samples across the three age groups were measured using QIIME. Overall diversity was lowest in the intermediate-age samples. Within treatment types, differences between age groups were tested using a Kruskal-Wallis test and Dunn’s post hoc test. The values are averages of five replicates, and significant P values are shown in boldface.
Versus 27,000 years.
Versus 33,000 years.
Versus 19,000 years.